Suchergebnisse - "Davies, Jane C"

PubPharm (16)

1

New concepts in antimicrobial resistance in cystic fibrosis respiratory infections

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2022

von Drevinek, P. | Canton, R. | Johansen, H. | +4

2

Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa

enthalten in: Microbiology spectrum | 2022

von Murphy, R. | Coates, M. | Thrane, S. | +6

3

Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane

enthalten in: eLife | 2021

von Sabnis, A. | Hagart, K. | Klöckner, A. | +10

4

Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Soren, O. | Rineh, A. | Silva, D. | +9

5

Impact of T2R38 Receptor Polymorphisms on Pseudomonas aeruginosa Infection in Cystic Fibrosis

enthalten in: American journal of respiratory and critical care medicine | 2018

von Turnbull, A. | Murphy, R. | Behrends, V. | +7

6

The Immunomodulatory Drug Glatiramer Acetate is Also an Effective Antimicrobial Agent that Kills Gram-negative Bacteria

enthalten in: Scientific reports | 2017

von Christiansen, S. | Murphy, R. | Juul-Madsen, K. | +15

7

Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis

enthalten in: FEMS microbiology letters | 2017

von Smith, W. | Bardin, E. | Cameron, L. | +19

8

Pseudomonas aeruginosa infection in cystic fibrosis : pathophysiological mechanisms and therapeutic approaches

enthalten in: Expert review of respiratory medicine | 2016

von Lund-Palau, H. | Turnbull, A. | Bush, A. | +21

9

Multiple breath washouts in children can be shortened without compromising quality

enthalten in: The European respiratory journal | 2015

von Ahmad, F. | Irving, S. | Alton, E. | +7

10

Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation

enthalten in: Thorax | 2013

von Horsley, A. | Davies, J. | Gray, R. | +29

CommentIn: Thorax. 2014 Feb;69(2):183. - PMID 23988751